Meetings

Addressing Viral Hepatitis Among Europe’s Migrant and Refugee Population: lessons learnt and the way forward (26-27 March 2024, Antwerp, Belgium)

LIST OF LEARNING OBJECTIVES FOR THIS ACTIVITY  

 Provide an overview of the available information concerning viral hepatitis among migrants and refugees in Europe, highlighting areas of concern and the associated public health threat.

    • Examine efforts aimed at enhancing healthcare access for migrants and refugees, with a particular focus on viral hepatitis prevention, vaccination, screening, diagnosis and treatment.
    • Evaluate the potential benefits and challenges of implementing guidelines for testing, treatment, and vaccination of migrants across Europe.
    • Explore potential collaborations among the different stakeholders to enhance viral hepatitis prevention and control efforts among migrants and refugees.
    • Lessons learnt from project and initiatives focusing on prevention and control of viral hepatitis in migrants
    • Discuss the relation to the WHO elimination goals outlined in the new WHO Global Health Sector Strategies for 2022-2030
    • Discuss achievements, challenges and the way forward.   

 Background document (693kb, Pdf) 

 

TUESDAY 26 MARCH 2024 – PART 1  

 

INTRODUCTION 

Chairs: Pierre Van Damme & Greet Hendrickx
09:00-09:40 

Welcome by Herman Van Goethem (Rector of the University of Antwerp, Belgium)  Meeting kickoff

Opening presentation, incl. introduction VHPB & meeting objectives Introduction of the participants  

 

SESSION 1.1: SETTING THE SCENE – MIGRATION AND VIRAL HEPATITIS IN EUROPE

09:40-10:00 

Migration in Europe and access to health services for migrants (ONLINE) (pdf, 0.863Mb)

Jozef Bartovic (WHO Euro)   

10:00-10:20 

The Forgotten people: Hepatitis B virus infection as a priority for the inclusion health agenda (pdf, 23.421Mb)

Philippa Matthews (University College London, UK)  

10:20-10:30  Q&A

 COFFEE BREAK 10:30-11:00

SESSION 1.2: HEPATITIS SCREENING AND BURDEN OF DISEASE IN EUROPEAN MIGRANTS

Chairs: Sema Mandal & Stéphane Chevaliez
11:00-11:15 

Hepatitis B and C virus infection and screening among migrants in EU/EEA countries. (pdf, 2.305Mb)

Ndeindo Ngrango Ndeikoundam (ECDC)  

11:15-11:30 

Point-of-care testing for hepatitis B and C in migrants in diverse community centres. (pdf, 4.33Mb)

Elisa Martró (Germans Trias i Pujol Hospital and Research Institute (IGTP), Spain)  

11:30-11:45 

Hepatitis A outbreak in a refugee shelter in Kiel, northern Germany

Anne Marcic (Public Health Department Kiel, Germany) (pdf, 1.187Mb)

Jürgen Wenzel (University Medical Center Regensburg, Germany) (pdf, 2.251Mb) 

11:45-12:00  

Value of community-based viral hepatitis strategies among migrants in Europe (VH-COMSAVAC) (pdf, 1.167Mb)

Melissa D’Agostino (Universita Cattolica del Sacro Cuore, Italy)  

12:00-12:15  

HEPARJOC: an educational tool to promote early hepatitis screening in migrants in Barcelona (pdf, 11.107Mb)

Jordi Gómez I Prat (University Hospital Vall d’Hebron, Spain)   

12:15-12:30 

Developing a well-accepted study design for people born outside Germany – the HepMig Pilot, Germany

Sandra Dudareva (Robert Koch Institute, Germany)  

12:30-12:50  Q&A

 LUNCH BREAK 12:50-13:50

 

SESSION 1.3: LINKAGE TO CARE, ACCESS TO TREATMENT AND HEALTH INEQUALITIES

Chairs: Camila Picchio & Rania Tohme
13:50-14:10

Health inequalities in the management of chronic hepatitis B virus infection in patients from sub-Saharan Africa in high-income countries. (pdf, 1.739Mb)

Geoffrey Dusheiko (King’s College Hospital, UK)  

14:10-14:30

Optimisation of linkage to care for hepatitis B/C infected ethnic minorities in Belgium. (pdf, 1.864Mb)

Thomas Vanwolleghem, (UZA/UA, Belgium)  

14:30-14:50

A Model to Eliminate Viral Hepatitis Infection in Migrants: A Prospective, Multicenter Study in Southern Italy (ONLINE) (pdf, 3.083Mb)

Mariantoinetta Pisaturo (University of Campania Luigi Vanvitelli, Italy)  

14:50-15:10

Viral hepatitis control in Ukrainian refugees in Poland (pdf, 1.724Mb)

Robert Flisiak (Medical University of Bialystok, Poland)  

15:10-15:30

Joint statement EASL, WHO Euro and ECDC: Ensuring high-quality viral hepatitis care for refugees from Ukraine. (pdf, 1.33Mb)

Maria Buti (EASL)

15:30-15:40  Q&A

COFFEE break 15:40-16:10 

 

SESSION 1.4: POINT OF VIEW OF INTERNATIONAL ORGANISATIONS SUPPORTING MIGRANT HEALTH

Chairs: Thomas Vanwolleghem & Sandra Dudareva
16:10-17:00

Panel discussion

ECDC – Ndeindo Ngrango Ndeikoundam 

WHO HQ – Antons Mozalevskis 

WHO Euro – Marcelo Naveira 

European Coalition for Migrants and Refugees – Suad Mohamed 

Médecins Du Monde – Ernst Wisse 

Doctors Without Borders – Jean-Paul Mangion

IOM – Cristina Profili International Centre for Migration

Health and Development (ICMHD) – Manuel Carballo (ONLINE)

SESSION 1.5: PREVENTION 

 

17:00-17:20

From AcToVax4NAM: General conceptual framework for understanding how to improve vaccination coverage among newly arrived migrants. (pdf, 4.212Mb)

Silvia Declich (ISS, Italy)  

17:20-17:40

Trends of acute hepatitis in migrants in Italy and potential impact of vaccinations. (pdf, 1.375Mb)

Maria Elena Tosti (ISS, Italy)  

17:40-18:10

Vaccination initiatives highlighted and open floor discussion

Mobile vaccination team in Flanders – Heidi Theeten (Zorg, Belgium) (pdf, 0.319Mb)

Vaccine initiatives within VH-COMSAVAC – Camila Picchio (ISGlobal, Spain) (pdf, 7.799Mb)

18:10 Closing of Day 1

DINNER at 19:30

WEDNESDAY 27 MARCH 2024 – PART 2

SESSION 2.1: NATIONAL POLICIES & INTERNATIONAL INITIATIVES ADDRESSING MIGRANT HEALTH INEQUALITIES

 

Chairs:  Angela Dominguez & Maria Buti
09:00-09:20

National policies for delivering hepatitis B and C virus infection services for refugees and migrants among member states of the WHO European Region. (pdf, 2.103Mb)

Antons Mozalevskis (WHO HQ) (pdf, 2.103Mb) & Marcelo Naveira (WHO Euro) (pdf, 0.546Mb) 

09:20-09:40

RIVER-EU: Reducing inequalities in vaccine uptake in the European Region – Engaging underserved communities. (pdf, 1.06Mb)

Pania Karnaki (Prolepsis Institute, Greece)  

09:40-10:00

Integrated services to better address the needs of migrants who use drugs (ONLINE)

Roberto Perez-Gayo (Correlation – European Harm Reduction Network)  

10:00-10:20

Potential of the electronic Personal Health Record system for migrants and refugees arriving in Europe (ONLINE) (pdf, 3.064Mb)

Ana Requena Méndez (Karolinska Institutet, Sweden)  

10:20-10:30

Cancer RADAR – mapping cancer risk by migration background in Europe (pdf, 1.95Mb)

Catharina (Nienke) Alberts (Amsterdam UMC, The Netherlands)

10:30-10:40 Q&A

COFFEE break 10:40-11:10

SESSION 2.2: GOOD PRACTICES AND THEIR POTENTIAL FOR EU WIDE IMPLEMENTATION

Chairs: Antons Mozalevskis & Mojca Maticic
11:10-12:10

GROUPS DISCUSSION: Improving care of migrants is key for viral hepatitis elimination in Europe

Discussion in 4 groups on the most important identified barriers and opportunities and how to move forward.  

12:10-12:40 Outcome of the groups discussions by group leaders & general discussion

LUNCH 12:40-14:10

SESSION 2.3: MEETING SUMMARY

Chairs: Marcelo Naveira & Françoise Roudot-Thoraval
14:10-14:40

Meeting summary (pdf, 0.552Mb)

David FitzSimons  

14:40-15:00 Closing remarks

Mdeon visum: 24/V2/15542/009367